While it is unclear whether the incidence of liver cancer is increased in leptin-deficient mice, there is no doubt that the risk for primary liver cancer is increased in humans with obesity-related liver disease, even in the absence of cirrhosis [60]. The gene discussed is LEP; the disease is Cirrhosis.